About 3 results found for searched term "AT7519" (0.126 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M1653 | AT7519 | CDK |
| AT7519 is a novel small molecule multi-cyclin-dependent (CDK) kinase inhibitor. | ||
| M3687 | AT7519 hydrochloride | CDK |
| AT7519 HCl | ||
| AT7519 hydrochloride is a multi-CDK inhibitor for CDK1, 2, 4, 6 and 9 with IC50 of 10-210 nM and induces apoptosis in multiple myeloma via GSK-3β activation and RNA polymerase II inhibition. | ||
| M13595 | AT7519 TFA | CDK |
| AT7519M TFA | ||
| AT7519 (AT7519M) TFA as a potent inhibitor of CDKs, with IC50s of 210, 47, 100, 13, 170, and <10 nM for CDK1, CDK2, CDK4 to CDK6, and CDK9, respectively. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
